Fut, nem toboroz1. fázis
Phase 1b study investigating the association of NP137 with Atezolizumab-Bevacizumab combination in first line in unresectable hepatocellular carcinoma
Key facts
- Where
- Angers Cedex 9, Bordeaux, Caen Cedex 9, Clichy, Grenoble Cedex 9, Lyon, Marseille, Nantes, Paris Cedex 12, Paris Cedex 13, Reims és Toulouse, FranciaországSee the 12 sites
- Phase
- 1. fázis
Where in Franciaország
- Centre Hospitalier Universitaire D AngersAngers Cedex 9, FranciaországNo longer taking part
- Centre hospitalier Universitaire de BordeauxBordeaux, FranciaországNo longer taking part
- Centre Hospitalier Universitaire De Caen NormandieCaen Cedex 9, FranciaországNo longer taking part
- Hopital BeaujonClichy, FranciaországNo longer taking part
- Centre Hospitalier Universitaire Grenoble AlpesGrenoble Cedex 9, FranciaországNo longer taking part
- Centre Leon BerardLyon, FranciaországNo longer taking part
- Hôpital Saint JosephMarseille, FranciaországNo longer taking part
- Centre Hospitalier Universitaire de NantesNantes, FranciaországNo longer taking part
- Hopital Saint AntoineParis Cedex 12, FranciaországNo longer taking part
- Pitie Salpetriere HospitalParis Cedex 13, FranciaországNo longer taking part
- Centre Hospitalier Universitaire de ReimsReims, FranciaországNo longer taking part
- Centre Hospitalier Universitaire de ToulouseToulouse, FranciaországNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University Hospital Grenoble
- Trial code
- EU 2022-500903-38-00
- Record updated
- 2026. szeptember 18.